
Блог
Останні Статті
Вибрані статті зі сцени Південної Флориди
Фільтри1
Категорія
Теги
NewsAlzheimer’s Blood Test Around Ages 53-69 May Help Detect Early Cognitive Decline
A new study has found that these biomarker blood tests may also help doctors find very early signs of cognitive decline in midlife adults without a dementia diagnosis.
NewsAt What Age Does Alzheimer’s Disease Begin? Mayo Clinic Study Points To Changes Decades Before Symptoms
By Kelsey Riegler Subtle biological changes linked to Alzheimer’s disease may begin as early as the late 50s — decades before memory loss or other symptoms appear — according to new research from Mayo Clinic.
NewsBlood Test Predicts Alzheimer’s Disease Progression Years Before Brain Scan Changes
A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before symptoms or signs appear on brain scans.
NewsThis Type of Brain Training May Actually Cut Your Alzheimer’s Risk
By Julia Ries Wexler – Fact checked by Nick Blackmer Could games designed to strengthen mental skills help prevent Alzheimer’s disease as you age? According to a new 20-year study, they may.1 More than 7 million Americans have Alzheimer’s disease, and that number is expected to rise to 13 million by 2050, according to the Alzheimer’s Association.2 There’s no proven way to prevent or cure the disease, but delaying its onset—even modestly—can help preserve and prolong people’s independence and quality of life. “That’s why expanding the menu of evidence-based prevention tools is so critical,” said Vernon Williams, MD, a sports neurologist and founding director […]...
NewsNew Blood Test ‘Clocks’ Could Predict Alzheimer’s Symptom Onset Years In Advance
Written by Peter Morales-Brown — Fact checked by Jill Seladi-Schulman, Ph.D. More than 7 million Americans are living with Alzheimer’s disease, and this number is projected to rise to nearly 13 million by 2050. By this estimation, health and long-term care costs for Alzheimer’s and other forms of dementia are projected to reach nearly $1 trillion in 2050. Predicting the onset of Alzheimer’s disease could be critically important for both clinical trials and practice, by offering a significant window for intervention. Current methods to help predict Alzheimer’s onset typically include brain imaging scans or spinal fluid tests. However, these tests can be expensive and difficult to access. Blood tests […]...